ArticleJournal of diabetes investigation2023

Impact of the angiotensin receptor-neprilysin inhibitor in clinical diabetes management: Potential benefits and pitfalls.

Tomoko Kato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.